NovaPump GmbH is developing and realising a leading solution for a novel right ventricular assist device (RVAD) with clear USPs (the only percutaneous device with pulsatile support).
NovaPump’s catheter-based heart pump PERKAT™ can be implanted within minutes in acute situations involving acute right heart failure, cardiogenic shock or acute right heart insufficiency and offers highly efficient pulsatile heart support in combination with the existing IABP (Intra-Aortic Balloon Pump) technology as a drive.
A perspective application of PERKAT™ as a bi-ventricular assist device (bi-VAD) is also planned for the near future.


Prof. Dr. Markus Ferrari

Ronald Reich


HTGF Series A financing NovaPump

Innovative Pulsatile Heart Pumps for Acute Patients: NovaPump secures seven-digit Financing Round NovaPump, one of the leading developers and medical product manufacturers of percutaneous circulatory mechanical support systems (pMCS) announced the successful closing of a…

High Tech Gruenderfonds Invests in NovaPump GmbH

The Jena-based heart technology firm NovaPump GmbH has successfully completed a first round of financing with High Tech Gruenderfonds in July 2013. This financing will support the development of a catheter-based procedure for right heart and biventricular support. The basic…

Info & Contact


Am Steinborn 103a
07749 Jena

In portfolio

28. Jun 2013